M Sterba Selected Research

Cardiotoxicity

9/2009	Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death.
9/2008	Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.
1/2007	Early detection of anthracycline cardiotoxicity in a rabbit model: left ventricle filling pattern versus troponin T determination.
1/2007	Evaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopathy: a useful tool for assessment of cardioprotective agents.
3/2005	Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Sterba Research Topics

Disease

5	Cardiotoxicity 09/2009 - 03/2005
2	Cardiomyopathies (Cardiomyopathy) 01/2007 - 03/2005
1	Left Ventricular Dysfunction 09/2009
1	Neoplasms (Cancer) 09/2008

Drug/Important Bio-Agent (IBA)

5	AnthracyclinesIBA 09/2009 - 03/2005
3	Daunorubicin (Cerubidine)FDA LinkGeneric 09/2009 - 03/2005
3	IronIBA 09/2008 - 03/2005
2	Troponin T (Troponin T1)IBA 09/2009 - 01/2007
2	Chelating AgentsIBA 01/2007 - 03/2005
1	Dexrazoxane (Zinecard)FDA LinkGeneric 09/2009
1	Antineoplastic Agents (Antineoplastics)IBA 09/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2008
1	salicylaldehyde isonicotinoyl hydrazoneIBA 09/2008
1	Cardiotonic Agents (Cardiac Stimulants)IBA 01/2007
1	Protective AgentsIBA 03/2005
1	Antineoplastic Antibiotics (Cytotoxic Antibiotics)IBA 03/2005
1	pyridoxal isonicotinoyl hydrazoneIBA 03/2005

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2007